Gorman, J., Du, R., Lai, Y.-T., Ahmadi, M. S., King, H. A. D., Song, K., Manalang, K., Gonelli, C. A., Schramm, C. A., Cheng, C., Nguyen, R., Ambrozak, D., Druz, A., Shen, C.-H., Yang, Y., Douek, D. C., Kwong, P. D., Roederer, M., & Mason, R. D. (2025). Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class. Cell Reports, 44(1), 115163. https://doi.org/10.1016/j.celrep.2024.115163

Cale, E. M., Shen, C.-H., Olia, A. S., Radakovich, N. A., Rawi, R., Yang, Y., Ambrozak, D. R., Bennici, A. K., Chuang, G.-Y., Crooks, E. D., Driscoll, J. I., Lin, B. C., Louder, M. K., Madden, P. J., Messina, M. A., Osawa, K., Stewart-Jones, G. B. E., Verardi, R., Vrakas, Z., … Gorman, J. (2024). A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies. Cell Reports, 43(12), 115010. https://doi.org/10.1016/j.celrep.2024.115010

Wang, Q., Guo, Y., Schwanz, L. T., Mellis, I. A., Sun, Y., Qu, Y., Urtecho, G., Valdez, R., Stoneman, E., Gordon, A., Wang, H. H., Ho, D. D., & Liu, L. (2024). SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1. Emerging Microbes & Infections, 13(1). https://doi.org/10.1080/22221751.2024.2359004

Reveiz, M., Xu, K., Lee, M., Wang, S., Olia, A. S., Harris, D. R., Liu, K., Liu, T., Schaub, A. J., Stephens, T., Wang, Y., Zhang, B., Huang, R., Tsybovsky, Y., Kwong, P. D., & Rawi, R. (2024). Vaccine-elicited and naturally elicited antibodies differ in their recognition of the HIV-1 fusion peptide. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1484029

Marcink, T. C., Zipursky, G., Sobolik, E. B., Golub, K., Herman, E., Stearns, K., Greninger, A. L., Porotto, M., & Moscona, A. (2024). How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-53082-y

Wang, Q., Mellis, I. A., Guo, Y., Gherasim, C., Valdez, R., Gordon, A., Ho, D. D., & Liu, L. (2024). Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster. Cell Reports Medicine, 5(9), 101701. https://doi.org/10.1016/j.xcrm.2024.101701

Suryadevara, N., Otrelo-Cardoso, A. R., Kose, N., Hu, Y.-X., Binshtein, E., Wolters, R. M., Greninger, A. L., Handal, L. S., Carnahan, R. H., Moscona, A., Jardetzky, T. S., & Crowe, J. E. (2024). Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies. Nature Microbiology, 9(8), 2128–2143. https://doi.org/10.1038/s41564-024-01722-w

Xu, J., Zhou, T., McKee, K., Zhang, B., Liu, C., Nazzari, A. F., Pegu, A., Shen, C., Becker, J. E., Bender, M. F., Chan, P., Changela, A., Chaudhary, R., Chen, X., Einav, T., Kwon, Y. D., Lin, B. C., Louder, M. K., Merriam, J. S., … Kwong, P. D. (2024). Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1. Advanced Science, 11(26). Portico. https://doi.org/10.1002/advs.202309268

Zyla, D. S., Della Marca, R., Niemeyer, G., Zipursky, G., Stearns, K., Leedale, C., Sobolik, E. B., Callaway, H. M., Hariharan, C., Peng, W., Parekh, D., Marcink, T. C., Diaz Avalos, R., Horvat, B., Mathieu, C., Snijder, J., Greninger, A. L., Hastie, K. M., Niewiesk, S., … Ollmann Saphire, E. (2024). A neutralizing antibody prevents postfusion transition of measles virus fusion protein. Science, 384(6703). https://doi.org/10.1126/science.adm8693

Olia, A. S., Prabhakaran, M., Harris, D. R., Cheung, C. S.-F., Gillespie, R. A., Gorman, J., Hoover, A., Morano, N. C., Ourahmane, A., Srikanth, A., Wang, S., Wu, W., Zhou, T., Andrews, S. F., Kanekiyo, M., Shapiro, L., McDermott, A. B., & Kwong, P. D. (2024). Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibody. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1399960

Jia, M., Zhao, H., Morano, N. C., Lu, H., Lui, Y.-M., Du, H., Becker, J. E., Yuen, K.-Y., Ho, D. D., Kwong, P. D., Shapiro, L., To, K. K.-W., & Wu, X. (2024). Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-48758-4

Wang, Q., Guo, Y., Bowen, A., Mellis, I. A., Valdez, R., Gherasim, C., Gordon, A., Liu, L., & Ho, D. D. (2024). XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1. Cell Host & Microbe, 32(3), 315-321.e3. https://doi.org/10.1016/j.chom.2024.01.014

Wang, Q., Yeh, A. Y., Guo, Y., Mohri, H., Yu, J., Ho, D. D., & Liu, L. (2023). Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2. Emerging Microbes & Infections, 12(1). https://doi.org/10.1080/22221751.2023.2210237

Wang, P., Casner, R. G., Nair, M. S., Yu, J., Guo, Y., Wang, M., Chan, J. F.-W., Cerutti, G., Iketani, S., Liu, L., Sheng, Z., Chen, Z., Yuen, K.-Y., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses. Emerging Microbes & Infections, 11(1), 147–157. https://doi.org/10.1080/22221751.2021.2011623

Khan, K., Karim, F., Cele, S., Reedoy, K., San, J. E., Lustig, G., Tegally, H., Rosenberg, Y., Bernstein, M., Jule, Z., Ganga, Y., Ngcobo, N., Mazibuko, M., Mthabela, N., Mhlane, Z., Mbatha, N., Miya, Y., Giandhari, J., Ramphal, Y., … Sigal, A. (2022). Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature, 607(7918), 356–359. https://doi.org/10.1038/s41586-022-04830-x

Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D. G., Karim, F., Bernstein, M., Lustig, G., Archary, D., Smith, M., Ganga, Y., Jule, Z., Reedoy, K., Hwa, S.-H., … Sigal, A. (2021). Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature, 602(7898), 654–656. https://doi.org/10.1038/s41586-021-04387-1

Liu, L., Iketani, S., Guo, Y., Chan, J. F.-W., Wang, M., Liu, L., Luo, Y., Chu, H., Huang, Y., Nair, M. S., Yu, J., Chik, K. K.-H., Yuen, T. T.-T., Yoon, C., To, K. K.-W., Chen, H., Yin, M. T., Sobieszczyk, M. E., Huang, Y., … Ho, D. D. (2021). Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature, 602(7898), 676–681. https://doi.org/10.1038/s41586-021-04388-0

Cele, S., Karim, F., Lustig, G., San, J. E., Hermanus, T., Tegally, H., Snyman, J., Moyo-Gwete, T., Wilkinson, E., Bernstein, M., Khan, K., Hwa, S.-H., Tilles, S. W., Singh, L., Giandhari, J., Mthabela, N., Mazibuko, M., Ganga, Y., Gosnell, B. I., … Sigal, A. (2022). SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host & Microbe, 30(2), 154-162.e5. https://doi.org/10.1016/j.chom.2022.01.005